Zobrazeno 1 - 10
of 131
pro vyhledávání: '"Merav, Leiba"'
Autor:
Hila Fishov, Eli Muchtar, Mali Salmon‐Divon, Angela Dispenzieri, Tal Zvida, Claudio Schneider, Benjamin Bender, Adrian Duek, Merav Leiba, Ofer Shpilberg, Oshrat Hershkovitz‐Rokah
Publikováno v:
Cancer Medicine, Vol 12, Iss 7, Pp 8199-8210 (2023)
Abstract Background Noncoding RNAs such as microRNAs (miRNAs) have attracted attention as biological pathway regulators, which differ from chromosomal translocations and gene point mutations. Their involvement in the molecular mechanisms underlying l
Externí odkaz:
https://doaj.org/article/e5211e65d69443ae94e2958b0db7e897
Publikováno v:
HemaSphere, Vol 7, p e25846d4 (2023)
Externí odkaz:
https://doaj.org/article/60148b467aa742649abe6de85f64194a
Publikováno v:
Renal Failure, Vol 44, Iss 1, Pp 1498-1500 (2022)
Externí odkaz:
https://doaj.org/article/c125d9f0a0584497a7fd5e2b09928055
Autor:
Jana Jakubikova, Danka Cholujova, Gabor Beke, Teru Hideshima, Lubos Klucar, Merav Leiba, Krzysztof Jamroziak, Paul G. Richardson, Efstathios Kastritis, David M. Dorfman, Kenneth C. Anderson
Publikováno v:
JCI Insight, Vol 8, Iss 3 (2023)
To better characterize the heterogeneity of multiple myeloma (MM), we profiled plasma cells (PCs) and their B cell lymphopoiesis in the BM samples from patients with monoclonal gammopathy of undetermined significance, smoldering MM, and active MM by
Externí odkaz:
https://doaj.org/article/efe61123c7494437b60474bd26dbea30
Autor:
Olga Ostrovsky, Katia Beider, Hila Magen, Merav Leiba, Ralph D. Sanderson, Israel Vlodavsky, Arnon Nagler
Publikováno v:
Cells, Vol 12, Iss 6, p 913 (2023)
Multiple myeloma (MM) is a plasma cell malignancy that is accompanied by hypercalcemia, renal failure, anemia, and lytic bone lesions. Heparanase (HPSE) plays an important role in supporting and promoting myeloma progression, maintenance of plasma ce
Externí odkaz:
https://doaj.org/article/96093207e230487dbe545e4390f6fa9f
Autor:
Paul G. Richardson, Arnon Nagler, Dina Ben‐Yehuda, Ashraf Badros, Parameswaran N. Hari, Roman Hajek, Ivan Spicka, Hakan Kaya, Richard LeBlanc, Sung‐Soo Yoon, Kihyun Kim, Joaquin Martinez‐Lopez, Moshe Mittelman, Ofer Shpilberg, Paul Blake, Teru Hideshima, Kathleen Colson, Jacob P. Laubach, Irene M. Ghobrial, Merav Leiba, Moshe E. Gatt, Peter Sportelli, Michael Chen, Kenneth C. Anderson
Publikováno v:
eJHaem, Vol 1, Iss 1, Pp 94-102 (2020)
Abstract Perifosine, an investigational, oral, synthetic alkylphospholipid, inhibits signal transduction pathways of relevance in multiple myeloma (MM) including PI3K/Akt. Perifosine demonstrated anti‐MM activity in preclinical studies and encourag
Externí odkaz:
https://doaj.org/article/4446319b4078465e9e6ff60dab4bc36c
Autor:
Hila Fishov, Eli Muchtar, Mali Salmon‐Divon, Angela Dispenzieri, Tal Zvida, Claudio Schneider, Benjamin Bender, Adrian Duek, Merav Leiba, Ofer Shpilberg, Oshrat Hershkovitz‐Rokah
Publikováno v:
Cancer Medicine. 12:8199-8210
Autor:
Tamir, Shragai, Hila, Magen, Noa, Lavi, Moshe, Gatt, Svetlana, Trestman, Miri, Zektser, Chezi, Ganzel, Osnat, Jarchowsky, Tamar, Berger, Tamar, Tadmor, Merav, Leiba, Katrin, Hertzog-Tzarfaty, Netanel, Horowitz, Michael, Shapira, David, Varssano, Yoav, Berger, Shahar, Frenkel, Mark, Krauthammer, Irit, Avivi, Efrat, Luttwak, Yael C, Cohen
Publikováno v:
British Journal of Haematology. 200:45-53
Belantamab mafodotin, an immuno-conjugate targeting B-cell maturation antigen, showed single-agent activity in phase 1 and 2 studies, and was recently approved for heavily pretreated relapsed/refractory multiple myeloma (RRMM) patients. Real-world da
Autor:
Ramón Garcia-Sanz, Marzia Varettoni, Cristina Jiménez, Simone Ferrero, Stephanie Poulain, Jesus F. San-Miguel, Maria L. Guerrera, Daniela Drandi, Tina Bagratuni, Mary McMaster, Aldo M. Roccaro, Damien Roos-Weil, Merav Leiba, Yong Li, Luigi Qiu, Jian Hou, C. Fernandez De Larrea, Jorge J. Castillo, M. Dimopoulos, R.G. Owen, S.P. Treon, Z.R. Hunter
Publikováno v:
Seminars in Hematology.
Autor:
María-Victoria Mateos, Heinz Ludwig, Ali Bazarbachi, Meral Beksac, Joan Bladé, Mario Boccadoro, Michele Cavo, Michel Delforge, Meletios A. Dimopoulos, Thierry Facon, Catarina Geraldes, Hartmut Goldschmidt, Roman Hájek, Markus Hansson, Krzysztof Jamroziak, Merav Leiba, Tamás Masszi, Larisa Mendeleeva, Michael O’Dwyer, Torben Plesner, Jesús F. San-Miguel, Christian Straka, Niels W.C.J. van de Donk, Kwee Yong, Samo Zver, Philippe Moreau, Pieter Sonneveld
Publikováno v:
HemaSphere, Vol 3, Iss 1 (2019)
Abstract. The introduction of new agents and management strategies over the past decade has resulted in a major step change in treatment outcomes with deepening responses and increased survival for patients with multiple myeloma. In daily clinical pr
Externí odkaz:
https://doaj.org/article/44eb0f2215ae44ac93dbe91263e0cfd0